Market Overview

Benzinga's Top #PreMarket Gainers


Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares rose 21.21 percent to $1.200 after the company reported that the U.S. FDA has granted Orphan Drug Designation to Pluristem's PLX-PAD cells.

Prima BioMed Ltd (ADR) (NASDAQ: PBMD) shares rose 12.61 percent to $1.25. Roth initiated coverage on PBMD with a Buy rating and a $6 price target.

Chimerix Inc (NASDAQ: CMRX) shares rose 7.90 percent to $9.01. Steven Cohen reported a 5.3 percent stake in Chimerix.

Perion Network Ltd (NASDAQ: PERI) shares rose 4.07 percent to $3.84 in pre-market trading after the company raised its Q4 forecast.

Vodafone Group Plc (ADR) (NASDAQ: VOD) shares rose 1.77 percent to $32.69 in pre-market trading after falling 0.86 percent on Wednesday.


Related Articles (PSTI + PBMD)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at